Meeder Asset Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Meeder Asset Management’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,229	Closed	-$11K	–	2460
2020 Q2	$11K	Buy	1,229 +100	+9%	+$862	﹤0.01%	1305
2020 Q1	$8K	Buy	1,129 +1,104	+4,416%	+$8.18K	﹤0.01%	1630
2019 Q4	$0	Buy	+25	New	+$187	﹤0.01%	2479
2019 Q3	–	Sell	-846	Closed	-$4K	–	2315
2019 Q2	$4K	Buy	846 +416	+97%	+$2.19K	﹤0.01%	1763
2019 Q1	$3K	Sell	430 -297	-41%	-$2.08K	﹤0.01%	1518
2018 Q4	$5K	Buy	+727	New	+$5.56K	﹤0.01%	1435
2017 Q2	–	Sell	-7	Closed	–	–	1955
2017 Q1	$0	Buy	+7	New	+$73	﹤0.01%	1755

Other funds holding NPTN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Meeder Asset Management's NPTN Position: Q3 2020 in Review

Meeder Asset Management sold out of NEOPHOTONICS CORP (NPTN) in Q3 2020, closing a stake of 1,229 shares — an estimated $11K sold.

Meeder Asset Management first reported a position in NPTN in Q1 2017 and held it in 7 quarters. The position peaked at $11K in Q2 2020. 140 funds tracked by Wall St. Rank hold NPTN as of Q3 2020.

Meeder Asset Management reported no remaining NEOPHOTONICS CORP position as of Q3 2020 after selling out during the quarter.
Meeder Asset Management sold 1,229 NEOPHOTONICS CORP shares in Q3 2020, an estimated $11K.
Meeder Asset Management first reported a position in NEOPHOTONICS CORP in Q1 2017 and held it in 7 quarters.
Meeder Asset Management's NEOPHOTONICS CORP position peaked at $11K in Q2 2020.
140 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2020.

Based on Meeder Asset Management's 13F filing for Q3 2020, filed 2 Nov 2020.